A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Camrelizumab (Primary)
- Indications Early breast cancer; Triple negative breast cancer
- Focus Therapeutic Use
- 24 Jul 2020 New trial record